Albert Labs International (FRA:VB50) Total Equity: €-0.31 Mil (As of Sep. 2023)


What is Albert Labs International Total Equity?

Albert Labs International FRA:VB50 Total Equity is €-0.31 Mil as of Sep. 2023.

Albert Labs International's total equity for the quarter that ended in Sep. 2023 was €-0.31 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Albert Labs International Total Equity Historical Data

* Premium members only.

The historical data trend for Albert Labs International's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert Labs International Total Equity Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Total Equity
-0.35 -0.25

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 -0.25 -0.26 -0.30 -0.31

Albert Labs International Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Albert Labs International's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=0.114-0.368
=-0.25

Albert Labs International's Total Equity for the quarter that ended in Sep. 2023 is calculated as

Total Equity=Total Assets(Q: Sep. 2023 )-Total Liabilities(Q: Sep. 2023 )
=0.045-0.352
=-0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €-0.31 Mil mean?
Albert Labs International (FRA:VB50) has a Total Equity of €-0.31 Mil as of Sep. 2023. The total amount of equity as record on a company's balance sheet. View historical data for Albert Labs International and its competitors.
Is Albert Labs International's Total Equity too high?
Albert Labs International's current Total Equity is €-0.31 Mil.
How does Albert Labs International's Total Equity compare to VRTX and REGN?
Albert Labs International's Total Equity of €-0.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Albert Labs International and its competitors. Albert Labs International's current Total Equity is €-0.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert Labs International stock overvalued right now?
Albert Labs International (FRA:VB50) has a current Total Equity of €-0.31 Mil. The current Total Equity is €-0.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Albert Labs International (FRA:VB50), the current Total Equity is €-0.31 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Albert Labs International Business Description

Address 201-6996 Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research, and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of a clinical pathway.